|
|
|
|
| LEADER |
01774nam a2200481 i 4500 |
| 001 |
ZAG01000542292 |
| 003 |
HR-ZaZAG |
| 005 |
20120829093618.0 |
| 007 |
ta |
| 008 |
100422s2010 ci a rm 000 0dhrv d |
| 035 |
|
|
|a (HR-ZaZAG)000542292
|
| 040 |
|
|
|a HR-ZaMFS
|b hrv
|c HR-ZaMFS
|e ppiak
|
| 041 |
0 |
|
|a hrv
|b eng
|
| 100 |
1 |
|
|a Skorić, Boško
|
| 245 |
1 |
0 |
|a Osobitosti otpornosti na antitrombocitne lijekove u bolesnika s akutnim infarktom miokarda sa ST-elevacijom liječenih standardnim dozama acetilsalicilne kiseline i klopidogrela :
|b disertacija /
|c Boško Skorić.
|
| 260 |
|
|
|a Zagreb :
|b [s. n.],
|c 2010.
|
| 300 |
|
|
|a 107 str. :
|b graf. prikazi ;
|c 30 cm.
|
| 500 |
|
|
|a Sažetak ; Summary
|
| 502 |
|
|
|a Doktorska disertacija, Medicinski fakultet Sveučilišta u Zagrebu, 2010
|
| 504 |
|
|
|a Bibliografija: str. 81-102
|
| 650 |
1 |
2 |
|a Drug Resistance
|
| 650 |
1 |
2 |
|a Myocardial Infarction
|x drug therapy
|
| 650 |
1 |
2 |
|a Platelet Aggregation Inhibitors
|x adverse effects
|
| 650 |
1 |
2 |
|a Platelet Aggregation Inhibitors
|x therapeutic use
|
| 650 |
2 |
2 |
|a Adult
|
| 650 |
2 |
2 |
|a Aged
|
| 650 |
2 |
2 |
|a Aspirin
|x therapeutic use
|
| 650 |
2 |
2 |
|a Blood Platelets
|x drug effects
|
| 650 |
2 |
2 |
|a Female
|e check tag
|
| 650 |
2 |
2 |
|a Hemorrhage
|x chemically induced
|
| 650 |
2 |
2 |
|a Humans
|e check tag
|
| 650 |
2 |
2 |
|a Male
|e check tag
|
| 650 |
2 |
2 |
|a Middle Aged
|
| 650 |
2 |
2 |
|a Prognosis
|
| 650 |
2 |
2 |
|a Thrombolytic Therapy
|
| 650 |
2 |
2 |
|a Ticlopidine
|x analogs and derivatives
|
| 650 |
2 |
2 |
|a Ticlopidine
|x therapeutic use
|
| 945 |
0 |
|
|a Mentor: Davor Miličić ;
|b 27. 09. 2010.
|
| 946 |
|
|
|a Ocjena rada: Anton Šmalcelj, Jadranka Sertić, Mijo Bergovec ;
|b Obrana rada: Anton Šmalcelj, Jadranka Sertić, Mijo Bergovec
|
| OWN |
|
|
|a MFSNZ
|
| 852 |
|
|
|b MFS
|